These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3078205)

  • 1. A tribute; and some personal reflections on the trials and tribulations of an immunological research project.
    Brent L
    Pol Arch Med Wewn; 1988; 80(2-3):124-7. PubMed ID: 3078205
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced allograft acceptance by multiple infusions of donor bone marrow in humans.
    Ricordi C; Karatzas T; Selvaggi G; Neri J; Fernandez H; Ruiz MP; Linetsky E; Kong SS; Webb M; Bottino R
    Transplant Proc; 1995 Dec; 27(6):3381. PubMed ID: 8540006
    [No Abstract]   [Full Text] [Related]  

  • 3. Canine islet allograft survival after donor specific vertebral body derived bone marrow cell transplantation without irradiation conditioning of the recipient.
    Brendel MD; Kong SS; Schachner RD; Qian T; Selvaggi G; Alejandro R; Mintz DH; Ricordi C
    Transplant Proc; 1995 Dec; 27(6):3174. PubMed ID: 8539895
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic tolerance to organ transplants.
    Sachs DH
    J Gastrointest Surg; 1999; 3(2):105-10. PubMed ID: 10885945
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys.
    Thomas JM; Carver FM; Foil MB; Hall WR; Adams C; Fahrenbruch GB; Thomas FT
    Transplantation; 1983 Jul; 36(1):104-6. PubMed ID: 6346606
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation from the personal viewpoint.
    Thomas ED
    Int J Hematol; 2005 Feb; 81(2):89-93. PubMed ID: 15765774
    [No Abstract]   [Full Text] [Related]  

  • 7. Fifty years of immunological tolerance.
    Baker PJ; Hraba T
    Folia Biol (Praha); 1998; 44(6):189-92. PubMed ID: 10730861
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulation: other approaches.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):309-24. PubMed ID: 3347955
    [No Abstract]   [Full Text] [Related]  

  • 9. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mabs: a new lease on life for transplant patients?
    Nasto B
    Nat Biotechnol; 1996 Oct; 14(10):1215. PubMed ID: 9631076
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cyclosporin A--a new immunosuppressive drug].
    Towpik E; Araujo JL; Kupiec-Wegliński J; Tilney NL
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1735-9. PubMed ID: 6395123
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic immunosuppressive strategies for the induction of allogeneic unresponsiveness in the adult host.
    Rapaport FT
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):114-7. PubMed ID: 3279603
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow transplants.
    Johnson PW; Orchard K
    BMJ; 2002 Aug; 325(7360):348-9. PubMed ID: 12183290
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cyclosporin A. Bright prospects for organ transplantation?].
    Dieperink H; Frandsen NE; Kemp E
    Ugeskr Laeger; 1983 Sep; 145(36):2749-52. PubMed ID: 6356544
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of BM allografting from C57BL/6 'nude' mice into C3H/HeJ recipients by tolerized T cells from (C57BL/6-->C3H/HeJ) and (C3H/HeJ-->C57BL/6) chimeras.
    Faktorowich Y; Lapidot T; Lubin I; Reisner Y
    Bone Marrow Transplant; 1993 Jul; 12(1):15-20. PubMed ID: 8374532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma immunoadsorption combined with exchange for removal of isohemagglutinin in major ABO-incompatible bone marrow transplantation: a case report.
    Akao Y; Matsuzaki M; Naito K; Naoe T; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1987 Sep; 50(6):1258-62. PubMed ID: 3318267
    [No Abstract]   [Full Text] [Related]  

  • 17. Delaying acute graft-versus-host disease in mouse bone marrow transplantation by treating donor cells with antibodies directed at l-selectin and alpha4-integrin prior to infusion.
    Li B; New JY; Tay YK; Goh E; Yap EH; Chan SH; Hu HZ
    Scand J Immunol; 2004 May; 59(5):464-8. PubMed ID: 15140056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nobel Prize in physiology and medicine 1990].
    Maleszka P; Kamiński G
    Pneumonol Alergol Pol; 1991; 59(1-2):68-70. PubMed ID: 1843891
    [No Abstract]   [Full Text] [Related]  

  • 19. Depletion of accessory cells strongly reduces immunogenicity of T-depleted bone marrow, and thus may facilitate its engraftment.
    Dreger P; Steinmann J; Löffler H; Müller-Ruchholtz W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2949-51. PubMed ID: 2523164
    [No Abstract]   [Full Text] [Related]  

  • 20. A personal tribute to Kerr L. White, M.D., my career mentor, colleague, and friend.
    Williamson JW
    Health Serv Res; 1997 Apr; 32(1):22-31. PubMed ID: 9108801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.